UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status

Journal of digital imaging, 2017-10, Vol.30 (5), p.622-628

2017

Link zum Volltext

Verfügbarkeit prüfen

Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma

Journal of neuro-oncology, 2008-11, Vol.90 (2), p.201-204

2008

Link zum Volltext

Verfügbarkeit prüfen

Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status

Journal of digital imaging, 2017-10, Vol.30 (5), p.622-628

2017

Link zum Volltext

Verfügbarkeit prüfen

Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales

Health and quality of life outcomes, 2014-12, Vol.12 (1), p.187-187, Article 187

2014

Link zum Volltext

Verfügbarkeit prüfen

Controversies in the Therapy of Low-Grade Gliomas

Current treatment options in oncology, 2019-04, Vol.20 (4), p.25-25, Article 25

2019

Link zum Volltext

Verfügbarkeit prüfen

The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma

Journal of neuro-oncology, 2017-12, Vol.135 (3), p.535-543

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

Journal of neuro-oncology, 2019-07, Vol.143 (3), p.573-581

2019

Link zum Volltext

Verfügbarkeit prüfen

Seizures in patients with primary brain tumors: what is their psychosocial impact?

Journal of neuro-oncology, 2016-06, Vol.128 (2), p.285-291

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM

Journal of neuro-oncology, 2010-08, Vol.99 (1), p.73-80

2010

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

Journal of neuro-oncology, 2019-07, Vol.143 (3), p.583-583

2019

Link zum Volltext

Verfügbarkeit prüfen

The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma

Journal of neuro-oncology, 2014-10, Vol.120 (1), p.85-93

2014

Link zum Volltext

Verfügbarkeit prüfen

Prospective study of quality of life in adults with newly diagnosed high-grade gliomas

Journal of neuro-oncology, 2006-02, Vol.76 (3), p.283-291

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer

Investigational new drugs, 2010-06, Vol.28 (3), p.334-342

2010

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model

Journal of neuro-oncology, 2009-03, Vol.92 (1), p.23-31

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumor

Journal of neuro-oncology, 2014-11, Vol.120 (2), p.371-379

2014

Link zum Volltext

Verfügbarkeit prüfen

Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma

Journal of neuro-oncology, 2012-11, Vol.110 (2), p.227-235

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results

Journal of neuro-oncology, 2009-04, Vol.92 (2), p.165-175

2009

Link zum Volltext

Verfügbarkeit prüfen

Choroid plexus papillomas: a single institutional experience

Journal of neuro-oncology, 2004-05, Vol.68 (1), p.49-55

2004

Link zum Volltext

Verfügbarkeit prüfen

Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic grade

Journal of neuro-oncology, 2007-09, Vol.84 (3), p.279-286

2007

Link zum Volltext

Verfügbarkeit prüfen

Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients

Journal of neuro-oncology, 2006-05, Vol.77 (3), p.315-320

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial

Investigational new drugs, 2005-10, Vol.23 (5), p.495-503

2005

Link zum Volltext

Verfügbarkeit prüfen

Triple-dose contrast/magnetization transfer suppressed imaging of 'non-enhancing' brain gliomas

Journal of neuro-oncology, 2002-10, Vol.60 (1), p.25-29

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma

Journal of neuro-oncology, 1998, Vol.36 (1), p.65-70

1998

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy for advanced CNS ependymoma

Journal of neuro-oncology, 1999, Vol.45 (1), p.61

1999

Link zum Volltext

Verfügbarkeit prüfen

A north central cancer treatment group phase II trial of topotecan in relapsed gliomas

Investigational new drugs, 2000-08, Vol.18 (3), p.275-280

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer

KollektionSpringerLink Journals - AutoHoldings

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

SpringerLink Journals (MCLS)
(35)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(32)
MEDLINE
(31)
Journals@Ovid Complete
(29)
EZB Electronic Journals Library
(5)
IngentaConnect Journals
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Neuro-Oncology
(22)
Investigational New Drugs
(5)
Bmc Cancer
(2)
Journal Of Digital Imaging
(2)
Breast Cancer Research And Treatment
(1)
Cancer And Metastasis Reviews
(1)
Current Treatment Options In Oncology
(1)
Health And Quality Of Life Outcomes
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status

Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma

Residual Deep Convolutional Neural Network Predicts MGMT Methylation Status

Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales

Controversies in the Therapy of Low-Grade Gliomas

The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

Seizures in patients with primary brain tumors: what is their psychosocial impact?

Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM

Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG)

The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma

Prospective study of quality of life in adults with newly diagnosed high-grade gliomas

Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer

Evaluation of MGMT promoter methylation status and correlation with temozolomide response in orthotopic glioblastoma xenograft model

Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumor

Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results

Choroid plexus papillomas: a single institutional experience

Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic grade

Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients

Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trial

Triple-dose contrast/magnetization transfer suppressed imaging of 'non-enhancing' brain gliomas

Phase II trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma

Chemotherapy for advanced CNS ependymoma

A north central cancer treatment group phase II trial of topotecan in relapsed gliomas

Aktive Filter

Suchergebnisse filtern